Primary Health Props - Director/PDMR Shareholding

Primary Health Properties

18/08/2026 14:30

RNS Number : 1710R
  
Primary Health Properties PLC
  
18 August 2026
  
 


Primary Health Properties PLC
("PHP" or the "Company"),
 
 
Director/PDMR Shareholding
 
 
The Company has been notified that the following information relating to the transaction detailed below has been filed with the FCA in accordance with Article 19(1) of the Market Abuse Regulation.




1


Details of person discharging managerial responsibilities/person closely associated




(a)


Name


Harry Hyman
 




2


Reason for notification




(a)


Position/Status


Non-executive Chair




(b)


Initial notification/amendment


Initial notification
 




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 




(a)


Name
 


Primary Health Properties PLC




(b)


LEI


213800Y5CJHXOATK7X11
 




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




(a)


Description of the financial instrument


Ordinary shares of 12.5p
ISIN: GB00BYRJ5J14




(b)


Nature of the transaction


Purchase by ISA under dividend re-investment plan




(c)


Price(s) and volume(s)


Price(s)


Volume(s)




£ 0.94898


4,597




(d)


Aggregated volume price


Single transaction
£4,362.46
 




(e)


Date of transaction


17 August 2026
 




(f)


Place of transaction


London Stock Exchange (xlon)
 




 
For further information
Primary Health Properties PLC
 
Phil Higgins, Company Secretary
CoSec@phpgroup.co.uk
 
Legal Entity Identifier: 213800Y5CJHXOATK7X11




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHBBGDIGDBDGLI